{"id":3735,"date":"2023-04-01T19:39:01","date_gmt":"2023-04-01T23:39:01","guid":{"rendered":"https:\/\/dev.claimsecure.com\/korsuvamd-le-premier-medicament-approuve-dans-le-traitement-du-prurit-associe-a-linsuffisance-renale-chronique\/"},"modified":"2024-04-11T16:36:02","modified_gmt":"2024-04-11T20:36:02","slug":"korsuvamd-le-premier-medicament-approuve-dans-le-traitement-du-prurit-associe-a-linsuffisance-renale-chronique","status":"publish","type":"post","link":"https:\/\/www.claimsecure.com\/fr\/korsuvamd-le-premier-medicament-approuve-dans-le-traitement-du-prurit-associe-a-linsuffisance-renale-chronique\/","title":{"rendered":"KORSUVA<sup>MD<\/sup> &#8211; le premier m\u00e9dicament approuv\u00e9 dans le traitement du prurit associ\u00e9 \u00e0 l\u2019insuffisance r\u00e9nale chronique"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"3735\" class=\"elementor elementor-3735 elementor-2431\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4f1e6f3 e-flex e-con-boxed e-con e-parent\" data-id=\"4f1e6f3\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7fea273 elementor-widget elementor-widget-text-editor\" data-id=\"7fea273\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h6><strong>Revue des m\u00e9dicaments: Volume 23, num\u00e9ro 4\u00a0<\/strong><em><a style=\"font-weight: bolder; text-align: var(--text-align); background-color: #ffffff;\" href=\"https:\/\/www.claimsecure.com\/wp-content\/uploads\/2024\/04\/4.-April-2023-Korsuva-Drug-Review-FR_FINAL-s-1.pdf\">(T\u00e9l\u00e9charger PDF)<\/a><\/em><strong><br \/><\/strong><\/h6><p>L\u2019insuffisance r\u00e9nale chronique (IRC) se caract\u00e9rise par une perte progressive et irr\u00e9versible de la fonction r\u00e9nale pendant plusieurs mois ou ann\u00e9es. Le prurit associ\u00e9 \u00e0 l\u2019insuffisance r\u00e9nale chronique est une maladie lourde causant aux patients atteints d\u2019insuffisance r\u00e9nale chronique des d\u00e9mangeaisons extr\u00eames dont la cause est ind\u00e9termin\u00e9e. Cette maladie touche plus fr\u00e9quemment les patients sous h\u00e9modialyse. Elle peut \u00eatre invalidante pour les patients, car elle a des r\u00e9percussions n\u00e9gatives sur la qualit\u00e9 de leur sommeil et peut causer des l\u00e9sions et des infections cutan\u00e9es en raison du besoin permanent de se gratter.<\/p><p>Les lignes directrices cliniques actuelles recommandent l\u2019utilisation de m\u00e9dicaments tels que les antihistaminiques (p. ex., Atarax) et les gabapentino\u00efdes (p. ex., Lyrica). Ces m\u00e9dicaments ne sont pas approuv\u00e9s par Sant\u00e9 Canada dans le traitement du prurit associ\u00e9 \u00e0 l\u2019insuffisance r\u00e9nale chronique, mais sont utilis\u00e9s comme traitement standard pour la plupart des patients. Toutefois, ils n\u2019offrent pas toujours un soulagement total.<\/p><p>Korsuva<sup>MD<\/sup> est le premier m\u00e9dicament approuv\u00e9 par Sant\u00e9 Canada dans le traitement du prurit associ\u00e9 \u00e0 l\u2019insuffisance r\u00e9nale chronique. Korsuva<sup>MD<\/sup> poss\u00e8de un mode d\u2019action unique, en ciblant certaines cellules nerveuses et immunitaires, ce qui lui donne des effets antiprurigineux et anti-inflammatoires.<\/p><p>Des essais cliniques ont d\u00e9montr\u00e9 que Korsuva<sup>MD<\/sup> r\u00e9duisait efficacement l\u2019intensit\u00e9 des d\u00e9mangeaisons et leur fardeau chez des patients atteints d\u2019une insuffisance r\u00e9nale chronique sous h\u00e9modialyse.<\/p><p>Le co\u00fbt annuel de Korsuva<sup>MD<\/sup> est nettement plus \u00e9lev\u00e9 que celui du traitement standard actuel. Korsuva<sup>MD<\/sup> sera donc soumis \u00e0 une Autorisation sp\u00e9ciale pour les groupes inscrits aux Listes de m\u00e9dicaments g\u00e9r\u00e9s de S\u00e9curIndemnit\u00e9.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-14db15c eael-table-align-center eael-dt-th-align-left elementor-widget elementor-widget-eael-data-table\" data-id=\"14db15c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"eael-data-table.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"eael-data-table-wrap\" data-table_id=\"14db15c\" id=\"eael-data-table-wrapper-14db15c\" data-custom_responsive=\"false\">\n\t\t\t<table class=\"tablesorter eael-data-table center\" id=\"eael-data-table-14db15c\">\n\t\t\t    <thead>\n\t\t\t        <tr class=\"table-header\">\n\t\t\t\t\t\t\t\t\t            <th class=\"\" id=\"\" colspan=\"\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"data-table-header-text\">Nom du m\u00e9dicament<\/span><\/th>\n\t\t\t        \t\t\t\t            <th class=\"\" id=\"\" colspan=\"\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"data-table-header-text\">Korsuva<sup>MD<\/sup><\/span><\/th>\n\t\t\t        \t\t\t\t        <\/tr>\n\t\t\t    <\/thead>\n\t\t\t  \t<tbody>\n\t\t\t\t\t\t\t\t\t\t\t<tr>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   \t\t\t\t\t\t\t\t\t\t\t<td colspan=\"\" rowspan=\"\" class=\"\" id=\"\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"td-content-wrapper\"><div class=\"td-content\">\n\t\t\t\t\t\t\t\t\t\t\t\t\tIngr\u00e9dient du m\u00e9dicament\t\t\t\t\t\t\t\t\t\t\t\t<\/div><\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   \t\t\t\t\t\t\t\t\t\t\t<td colspan=\"\" rowspan=\"\" class=\"\" id=\"\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"td-content-wrapper\"><div class=\"td-content\">\n\t\t\t\t\t\t\t\t\t\t\t\t\tDif\u00e9lik\u00e9faline\t\t\t\t\t\t\t\t\t\t\t\t<\/div><\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/tr>\n\t\t\t        \t\t\t\t\t\t<tr>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   \t\t\t\t\t\t\t\t\t\t\t<td colspan=\"\" rowspan=\"\" class=\"\" id=\"\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"td-content-wrapper\"><div class=\"td-content\">\n\t\t\t\t\t\t\t\t\t\t\t\t\tCo\u00fbt annuel\t\t\t\t\t\t\t\t\t\t\t\t<\/div><\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   \t\t\t\t\t\t\t\t\t\t\t<td colspan=\"\" rowspan=\"\" class=\"\" id=\"\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"td-content-wrapper\"><div class=\"td-content\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t4 212 $\t\t\t\t\t\t\t\t\t\t\t\t<\/div><\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/tr>\n\t\t\t        \t\t\t\t\t\t<tr>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   \t\t\t\t\t\t\t\t\t\t\t<td colspan=\"\" rowspan=\"\" class=\"\" id=\"\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"td-content-wrapper\"><div class=\"td-content\">\n\t\t\t\t\t\t\t\t\t\t\t\t\tD\u00e9tails de la couverture\t\t\t\t\t\t\t\t\t\t\t\t<\/div><\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   \t\t\t\t\t\t\t\t\t\t\t<td colspan=\"\" rowspan=\"\" class=\"\" id=\"\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"td-content-wrapper\"><div class=\"td-content\">\n\t\t\t\t\t\t\t\t\t\t\t\t\tAutorisation sp\u00e9ciale\t\t\t\t\t\t\t\t\t\t\t\t<\/div><\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/tr>\n\t\t\t        \t\t\t    <\/tbody>\n\t\t\t<\/table>\n\t\t<\/div>\n\t  \t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cb61084 elementor-widget elementor-widget-text-editor\" data-id=\"cb61084\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>S\u00e9curIndemnit\u00e9 Inc. se r\u00e9serve le droit de modifier en partie, ou en totalit\u00e9, ses directives relatives \u00e0 l\u2019autorisation sp\u00e9ciale.<\/p><p>\u00a0<\/p><p>R\u00e9f\u00e9rences :<\/p><ol><li>Monographie de produit de Korsuva<sup>MD<\/sup>. Otsuka Canada Inc. Ao\u00fbt 2022.<\/li><li>KDIGO 2019 Chronic Kidney Disease associated pruiritis Guideline (Lignes directrices relatives au prurit associ\u00e9 \u00e0 l\u2019insuffisance r\u00e9nale chronique)<\/li><\/ol><p>\u00a0<\/p><p>\u00a92023 S\u00e9curIndemnit\u00e9 Inc.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Revue des m\u00e9dicaments: Volume 23, num\u00e9ro 4\u00a0(T\u00e9l\u00e9charger PDF) L\u2019insuffisance r\u00e9nale chronique (IRC) se caract\u00e9rise par une perte progressive et irr\u00e9versible de la fonction r\u00e9nale pendant plusieurs mois ou ann\u00e9es. Le prurit associ\u00e9 \u00e0 l\u2019insuffisance r\u00e9nale chronique est une maladie lourde causant aux patients atteints d\u2019insuffisance r\u00e9nale chronique des d\u00e9mangeaisons extr\u00eames dont la cause est ind\u00e9termin\u00e9e. [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":5273,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","inline_featured_image":false,"footnotes":""},"categories":[63],"tags":[],"class_list":["post-3735","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-revue-des-medicaments"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.claimsecure.com\/fr\/wp-json\/wp\/v2\/posts\/3735","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.claimsecure.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.claimsecure.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.claimsecure.com\/fr\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.claimsecure.com\/fr\/wp-json\/wp\/v2\/comments?post=3735"}],"version-history":[{"count":17,"href":"https:\/\/www.claimsecure.com\/fr\/wp-json\/wp\/v2\/posts\/3735\/revisions"}],"predecessor-version":[{"id":7587,"href":"https:\/\/www.claimsecure.com\/fr\/wp-json\/wp\/v2\/posts\/3735\/revisions\/7587"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.claimsecure.com\/fr\/wp-json\/wp\/v2\/media\/5273"}],"wp:attachment":[{"href":"https:\/\/www.claimsecure.com\/fr\/wp-json\/wp\/v2\/media?parent=3735"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.claimsecure.com\/fr\/wp-json\/wp\/v2\/categories?post=3735"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.claimsecure.com\/fr\/wp-json\/wp\/v2\/tags?post=3735"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}